• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lakewood-Amedex Biotherapeutics Inc. - Common Stock (NQ:LABT)

0.7822 -0.0098 (-1.24%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 118,134
Open 0.7931
Bid (Size) 0.7703 (1,600)
Ask (Size) 0.7840 (1,000)
Prev. Close 0.7920
Today's Range 0.7800 - 0.8211
52wk Range 0.7610 - 98.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
October 07, 2026
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) today announced positive preclinical data in urinary tract infection (UTI) and pulmonary infection indications in animal models treated with... 
Via B2i Digital
News headline image
Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape
October 07, 2026
From Insulin Management To Cell Replacement: The Diabetes Revolution Is Accelerating New York, NY – October 7, 2026 – Diabetes cell therapy is moving into a very different phase. For years, the idea of... 
Via FinancialNewsMedia

Performance

52-Week Range 99.2% below 52-week high
0.7822
0.7652W Low 98.2052W High
1 Week 13.1% below 1-week high
0.761W Low 0.901W High

Lakewood-Amedex Biotherapeutics Inc. - Common Stock (LABT) traded between $0.76 and $98.20 over the past 52 weeks and last traded at $0.78, 99.2% below its 52-week high. Over the past week it ranged between $0.76 and $0.90.

Past 12 Months
-8.5%
-61.8%
-71.3%
-99.1%
-99.1%
-99.1%
1W -$0.07
1M -$1.27
3M -$1.95
6M -$85.72
YTD -$85.72
1Y -$85.72

LABT was -99.1% over the past year, -99.1% over six months, -99.1% year to date, -8.5% in the last week.

12 Months vs Market
LABT
-99.1%
DIA
+13.5%
SPY
+19.2%
QQQ
+27.4%
IWM
+17.3%

Over the past 12 months LABT returned -99.1% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.

Volume & Liquidity 0.05× 3-mo avg
Today 118,134 3-mo avg 2.5M
1W
1.9M
1M
2.2M
3M
2.5M
6M
1.5M
YTD
1.5M
1Y
1.5M

LABT most recently traded 118,134 shares against a 3-month average daily volume of 2.5M.

More News

Read More
News headline image
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
October 01, 2026
Via B2i Digital
News headline image
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
September 28, 2026
Via B2i Digital
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
September 28, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
September 28, 2026
Via Chartmill
News headline image
Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers
September 24, 2026
Via B2i Digital
News headline image
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
September 21, 2026
Via B2i Digital
Topics Intellectual Property
News headline image
Lakewood-Amedex announces IRB approval and clinical site readiness for the Phase 2a trial of Nu-3
September 18, 2026
Via B2i Digital
The trading volume of these stocks is deviating from the norm in today's session. ↗
September 01, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 01, 2026
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 31, 2026
Via Benzinga
Wondering what's happening in today's after-hours session? ↗
August 31, 2026
Via Chartmill
News headline image
Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company
August 25, 2026
Via NewMediaWire
Topics Derivatives
News headline image
Tech Stocks LABT, ANY, INLF, GMGMF, ZCMD Under $2 Watch Now
July 23, 2026
Via AB Newswire
Topics Artificial Intelligence
Top movers analysis one hour before the close of the markets on 2026-07-22: top gainers and losers in today's session. ↗
July 22, 2026
Via Chartmill
Curious about the most active stocks on Wednesday? ↗
July 22, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
July 22, 2026
Via Benzinga
Top movers analysis in the middle of the day on 2026-07-22: top gainers and losers in today's session. ↗
July 22, 2026
Via Chartmill
Gapping stocks in Wednesday's session ↗
July 22, 2026
Via Chartmill
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
From Virtual Investor Conferences
Via GlobeNewswire

Frequently Asked Questions

Is Lakewood-Amedex Biotherapeutics Inc. - Common Stock publicly traded?
Yes, Lakewood-Amedex Biotherapeutics Inc. - Common Stock is publicly traded.
What exchange does Lakewood-Amedex Biotherapeutics Inc. - Common Stock trade on?
Lakewood-Amedex Biotherapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The ticker symbol for Lakewood-Amedex Biotherapeutics Inc. - Common Stock is LABT on the Nasdaq Stock Market
What is the current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock?
The current price of Lakewood-Amedex Biotherapeutics Inc. - Common Stock is 0.7822
When was Lakewood-Amedex Biotherapeutics Inc. - Common Stock last traded?
The last trade of Lakewood-Amedex Biotherapeutics Inc. - Common Stock was at 10/09/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap